Bench to Community Seminar - Series 1, Session 5: FDA Regulatory Pathways and Requirements
From Laura Osborne on March 19th, 2021
This session will provide an overview of regulatory approval and commercialization issues impacting companies developing medical devices, drugs, and biologic products. Attendees will be able to identify which regulatory pathways are likely to apply to their products, meaning that they will be able to more accurately predict the level of funding, research, commercialization strategies they will need to bring their product to market. In addition, attendees who are considering turning their products into companies will be given a better understanding of how to approach some common legal issues.